[PDF][PDF] Potential and opportunities for use of recombinant lactic acid bacteria in human health

S Hanniffy, U Wiedermann, A Repa, A Mercenier… - Adv Appl …, 2004 - academia.edu
Dietary lactic acid bacteria (LAB) are mostly known for their widespread use in the
production and preservation of fermented foods and as such have obtained the ''generally …

Delays in assessment of patients with rheumatoid arthritis: variations across Europe

…, P Sidiropoulos, E Kteniadaki, A Repa… - Annals of the …, 2011 - ard.bmj.com
Objective The first 3 months after symptom onset represent an important therapeutic window
for rheumatoid arthritis (RA). This study investigates the extent and causes of delay in …

[HTML][HTML] Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis

C Choulaki, G Papadaki, A Repa, E Kampouraki… - Arthritis research & …, 2015 - Springer
Abstract Introduction Interleukin-1β (IL-1β) is a major inflammatory cytokine, produced
predominantly by innate immune cells through NLRP3-inflammasome activation. Both …

Epidemiology and burden of systemic lupus erythematosus in a Southern European population: data from the community-based lupus registry of Crete, Greece

I Gergianaki, A Fanouriakis, A Repa… - Annals of the …, 2017 - ard.bmj.com
Objectives Several population-based studies on systemic lupus erythematosus (SLE) have
been reported, yet community-based, individual-case validated, comprehensive reports are …

Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1

C Daniel, A Repa, C Wild, A Pollak, B Pot… - Allergy, 2006 - Wiley Online Library
Background: Probiotic lactic acid bacteria (LAB) are able to modulate the host immune
system and clinical trials have demonstrated that specific strains have the capacity to reduce …

Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy

A Repa, C Grangette, C Daniel, R Hochreiter… - Vaccine, 2003 - Elsevier
Recent epidemiological studies and clinical trials suggest a possible role of certain lactic
acid bacteria (LAB) strains in the prevention of allergic diseases. In this study, we aimed at …

Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity

…, C Pamfil, A Fanouriakis, D Kosmara, A Repa… - Annals of the …, 2019 - ard.bmj.com
Objectives Systemic lupus erythematosus (SLE) diagnosis and treatment remain empirical
and the molecular basis for its heterogeneity elusive. We explored the genomic basis for …

[HTML][HTML] Probiotics (Lactobacillus acidophilus and Bifidobacterium bifidum) prevent NEC in VLBW infants fed breast milk but not formula

A Repa, M Thanhaeuser, D Endress, M Weber… - Pediatric …, 2015 - nature.com
Background: Specific probiotics prevent necrotizing enterocolitis (NEC). A mixture of
lactobacilli and bifidobacteria (Infloran) was highly effective in Asian very-low-birth-weight …

Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus

…, D Nikolopoulos, M Nikoloudaki, A Repa… - Annals of the …, 2021 - ard.bmj.com
Objectives Diagnostic reasoning in systemic lupus erythematosus (SLE) is a complex
process reflecting the probability of disease at a given timepoint against competing …

[HTML][HTML] A mixed lipid emulsion for prevention of parenteral nutrition associated cholestasis in extremely low birth weight infants: a randomized clinical trial

A Repa, C Binder, M Thanhaeuser, A Kreissl… - The Journal of …, 2018 - Elsevier
Objectives To examine whether a mixed lipid emulsion reduces the incidence of parenteral
nutrition associated cholestasis (PNAC) in extremely low birth weight (ELBW,< 1000 g) …